NCT01583218 2023-08-07APEXAlexion Pharmaceuticals, Inc.Phase 3 Completed7,513 enrolled 18 charts 1 FDA
NCT01444612 2017-05-16Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related SurgeryGlaxoSmithKlineCompleted4,068 enrolled
NCT00723216 2010-04-05Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer SurgerySanofiPhase 3 Completed151 enrolled